Company / Revenue
IRADIMED CORP Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$83.8M
FY2025
5-year range
$38.5M / $83.8M
FY2021-FY2025
Trend
+14.4%
vs FY2024
Sector context
#150 of 156
Health Care
What the data says
Among 156 Health Care companies, IRADIMED CORP is in the bottom 4% for revenue. Revenue has increased for 5 consecutive years, from $32M in FY2020 to $84M in FY2025.
Based on SEC 10-K filings.
$84M in FY2025 with a 5-year CAGR of +21.5%.
Improved from $66M to $84M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +26.1%
- 5-Year CAGR
- +21.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 156This company $83.8M Sector average $19.0B
▼
-99.6% below sector average
Key checks
Key Insights
- IRADIMED CORP's revenue has grown for 5 consecutive years.
- 5-year CAGR of +21.5%, indicating consistent growth.
- In FY2025, revenue increased 14.4% year-over-year.
- Ranks #150 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $83.8M | +14.4% |
| FY2024 | $73.2M | +11.7% |
| FY2023 | $65.6M | +56.8% |
| FY2022 | $41.8M | +8.6% |
| FY2021 | $38.5M | +21.4% |
| FY2020 | $31.7M | -17.7% |
| FY2019 | $38.5M | +18.5% |
| FY2018 | $32.5M | +2.9% |
| FY2017 | $31.6M | +101.8% |
| FY2016 | $15.7M | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026